The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Interleukin-10 and the immune response against cancer: a counterpoint
Abstract
Although interleukin-10 (IL-10) is commonly regarded as an anti-inflammatory, immunosuppressive cytokine that favors tumor escape from immune surveillance, a wealth of evidence is accumulating that IL-10 also possesses some immunostimulating properties. In fact, IL-10 has the pleiotropic ability of influencing positively and negatively the function of innate and adaptive immunity in different experimental models, which makes it questionable to merely categorize this cytokine as a target of anti-immune escape therapeutic strategies or rather, as an immunological adjuvant in the fight against cancer. Here, we review available data about the immunostimulating anticancer properties of IL-10, and in particular, we focus on the hypothesis that in contrast to what occurs in secondary lymphoid organs, IL-10 overexpression within the tumor microenvironment may catalyze cancer immune rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Self-citationBlockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314
Akbari, O., DeKruyff, R. H., & Umetsu, D. T. (2001) · Nature Immunology · doi:10.1038/90667 · Cited by 1,205
Danger signals: SOS to the immune system
Gallucci, S., & Matzinger, P. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00191-6 · Cited by 1,204
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Self-citationReciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells
Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G., & Trinchieri, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010938 · Cited by 1,028
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
T-cell subsets (Th1 versus Th2)
Romagnani, S. (2000) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62426-x · Cited by 815
Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S., & Levings, M. K. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820105.x · Cited by 814
Wakkach, A., Fournier, N., Brun, V., Breittmayer, J.-P., Cottrez, F., & Groux, H. (2003) · Immunity · doi:10.1016/s1074-7613(03)00113-4 · Cited by 788
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M. G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.19 · Cited by 777
Natural killer cells and dendritic cells: rendezvous in abused tissues
Moretta, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri956 · Cited by 704
Vieira, P. L., Christensen, J. R., Minaee, S., O’Neill, E. J., Barrat, F. J., Boonstra, A., Barthlott, T., Stockinger, B., Wraith, D. C., & O’Garra, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5986 · Cited by 654
Formyl-peptide receptors revisited
LE, Y., MURPHY, P., & WANG, J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02316-5 · Cited by 597
Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions
Corinti, S., Albanesi, C., la Sala, A., Pastore, S., & Girolomoni, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4312 · Cited by 555
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. H. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 511
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction
Ochsenbein, A. F., Sierro, S., Odermatt, B., Pericin, M., Karrer, U., Hermans, J., Hemmi, S., Hengartner, H., & Zinkernagel, R. M. (2001) · Nature · doi:10.1038/35082583 · Cited by 493
At the Crossroads of Inflammation and Cancer
Clevers, H. (2004) · Cell · doi:10.1016/j.cell.2004.09.005 · Cited by 493
Huang, M., Stolina, M., Sharma, S. P., Mao, J. T., Zhu, L. X., Miller, P. W., Wollman, J. S., Herschman, H. R., & Dubinett, S. M. (1998) · PubMed · Cited by 492
Allavena, P., Piemonti, L., Longoni, D., Bernasconi, S., Stoppacciaro, A., Ruco, L., & Mantovani, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<359::aid-immu359>3.0.co;2-4 · Cited by 486
Stolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.361 · Cited by 465
Mocellin, S. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00009-1 · Cited by 463
Self-citationSteinbrink, K., Graulich, E., Kubsch, S., Knop, J., & Enk, A. H. (2002) · Blood · doi:10.1182/blood.v99.7.2468 · Cited by 448
Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
Enk, A. H., Jonuleit, H., Saloga, J., & Knop, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971104)73:3<309::aid-ijc1>3.0.co;2-3 · Cited by 386
Mechanisms of interleukin‐10‐mediated immune suppression
Akdis, C. A., & Blaser, K. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01235.x · Cited by 382
Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M.-G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3188 · Cited by 376
Zippelius, A., Batard, P., Rubio-Godoy, V., Bioley, G., Liénard, D., Lejeune, F., Rimoldi, D., Guillaume, P., Meidenbauer, N., Mackensen, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3066 · Cited by 361
Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection
Kelly, J. M., Darcy, P. K., Markby, J. L., Godfrey, D. I., Takeda, K., Yagita, H., & Smyth, M. J. (2002) · Nature Immunology · doi:10.1038/ni746 · Cited by 356
Priming of naive T cells inside tumors leads to eradication of established tumors
Yu, P., Lee, Y., Liu, W., Chin, R. K., Wang, J., Wang, Y., Schietinger, A., Philip, M., Schreiber, H., & Fu, Y.-X. (2004) · Nature Immunology · doi:10.1038/ni1029 · Cited by 356
Oswald, I. P., Wynn, T. A., Sher, A., & James, S. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8676 · Cited by 353
Vicari, A. P., Chiodoni, C., Vaure, C., Aït-Yahia, S., Dercamp, C., Matsos, F., Reynard, O., Taverne, C., Merle, P., Colombo, M. P., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020732 · Cited by 343
Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance
Mapara, M. Y., & Sykes, M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.041 · Cited by 325
Kim, J., Modlin, R. L., Moy, R. L., Dubinett, S. M., McHugh, T., Nickoloff, B. J., & Uyemura, K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2240 · Cited by 323
Proinflammatory Effects of IL-10 During Human Endotoxemia
Lauw, F. N., Pajkrt, D., Hack, C. E., Kurimoto, M., van Deventer, S. J. H., & van der Poll, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2783 · Cited by 318
Cytokines in pancreatic carcinoma: Correlation with phenotypic characteristics and prognosis
Ebrahimi, B., Tucker, S. L., Li, D., Abbruzzese, J. L., & Kurzrock, R. (2004) · Cancer · doi:10.1002/cncr.20672 · Cited by 315
(2001) · PubMed · Cited by 279
Altered Immune Responses in Interleukin 10 Transgenic Mice
Hagenbaugh, A., Sharma, S., Dubinett, S. M., Wei, S. H.-Y., Aranda, R., Cheroutre, H., Fowell, D. J., Binder, S., Tsao, B., Locksley, R. M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2101 · Cited by 269
Iwahashi, M., Yamamura, M., Aita, T., Okamoto, A., Ueno, A., Ogawa, N., Akashi, S., Miyake, K., Godowski, P. J., & Makino, H. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20219 · Cited by 267
Cytokines and Immune Response in the Tumor Microenvironment
Mocellin, S., Wang, E., & Marincola, F. M. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200109000-00002 · Cited by 259
Self-citationYue, F. Y., Dummer, R., Geertsen, R., Hofbauer, G. F. L., Laine, E., Manolio, S., & Burg, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970516)71:4<630::aid-ijc20>3.0.co;2-e · Cited by 257
Differential expression of Toll-like receptor 2 in human cells
Flo, T. H., Halaas, Ø., Torp, S., Ryan, L., Lien, E., Dybdahl, B., Sundan, A., & Espevik, T. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.3.474 · Cited by 255
Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys
D'Amico, G., Frascaroli, G., Bianchi, G., Transidico, P., Doni, A., Vecchi, A., Sozzani, S., Allavena, P., & Mantovani, A. (2000) · Nature Immunology · doi:10.1038/80819 · Cited by 252
T Cell-Derived IL-10 Promotes Lung Cancer Growth by Suppressing Both T Cell and APC Function
Sharma, S., Stolina, M., Lin, Y., Gardner, B., Miller, P. W., Kronenberg, M., & Dubinett, S. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5020 · Cited by 250
Yang, L., Yamagata, N., Yadav, R., Brandon, S., Courtney, R. L., Morrow, J. D., Shyr, Y., Boothby, M., Joyce, S., Carbone, D. P., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16492 · Cited by 250
Groux, H., Cottrez, F., Rouleau, M., Mauze, S., Antonenko, S., Hurst, S., McNeil, T., Bigler, M., Roncarolo, M.-G., & Coffman, R. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1723 · Cited by 247
Mocellin, S., Marincola, F., Riccardo Rossi, C., Nitti, D., & Lise, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.11.001 · Cited by 247
Self-citationCurrent uses of isolated limb perfusion in the clinic and a model system for new strategies
Eggermont, A. M., de Wilt, J. H., & ten Hagen, T. L. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01141-0 · Cited by 235
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.
Sharma, S. P., Stolina, M., Yang, S.-C., Baratelli, F. E., Lin, J. F.-H., Atianzar, K., Luo, J., Zhu, L., Lin, Y., Huang, M., et al. (2003) · PubMed · Cited by 232
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.
Zheng, L. M., Ojcius, D. M., Garaud, F., Roth, C., Maxwell, E., Li, Z., Rong, H., Chen, J., Wang, X. Y., Catino, J. J., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.579 · Cited by 230
Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes
Sozzani, S., Ghezzi, S., Iannolo, G., Luini, W., Borsatti, A., Polentarutti, N., Sica, A., Locati, M., Mackay, C., Wells, T. N. C., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.439 · Cited by 229
Tumor–Host Immune Interactions and Dendritic Cell Dysfunction
(2004) · Advances in Cancer Research · doi:10.1016/s0065-230x(04)92002-7 · Cited by 223
Erdman, S. E., Rao, V. P., Poutahidis, T., Ihrig, M. M., Ge, Z., Feng, Y., Tomczak, M. F., Rogers, A. B., Horwitz, B. H., & Fox, J. G. (2003) · PubMed · Cited by 210
Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ
Fujii, S.-I., Shimizu, K., Shimizu, T., & Lotze, M. T. (2001) · Blood · doi:10.1182/blood.v98.7.2143 · Cited by 208
Seo, N., Hayakawa, S., Takigawa, M., & Tokura, Y. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01279.x · Cited by 206
Berman, R. M., Suzuki, T., Tahara, H., Robbins, P. D., Narula, S. K., & Lotze, M. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.231 · Cited by 205
Tumors as elusive targets of T-cell-based active immunotherapy
Marincola, F. M., Wang, E., Herlyn, M., Seliger, B., & Ferrone, S. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00116-9 · Cited by 202
Self-citationDemangel, C., Bertolino, P., & Britton, W. J. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200204)32:4<994::aid-immu994>3.0.co;2-6 · Cited by 196
Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta.
Zeller, J. C., Panoskaltsis‐Mortari, A., Murphy, W. J., Ruscetti, F. W., Narula, S. K., Roncarolo, M., & Blazar, B. R. (1999) · PubMed · Cited by 189
Natural killer cells determine the outcome of B cell–mediated autoimmunity
Shi, F.-D., Wang, H.-B., Li, H., Hong, S., Taniguchi, M., Link, H., Kaer, L. V., & Ljunggren, H.-G. (2000) · Nature Immunology · doi:10.1038/79792 · Cited by 187
Lech-Maranda, E. (2004) · Blood · doi:10.1182/blood-2003-06-1850 · Cited by 187
Suzuki, T., Tahara, H., Narula, S., Moore, K. W., Robbins, P. D., & Lotze, M. T. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.477 · Cited by 185
Inducing autoimmune disease to treat cancer
Pardoll, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5340 · Cited by 183
Giovarelli, M., Musiani, P., Modesti, A., Dellabona, P., Casorati, G., Allione, A., Consalvo, M., Cavallo, F., di Pierro, F., & De Giovanni, C. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.6.3112 · Cited by 180
Jinquan, T., Larsen, C. G., Gesser, B., Matsushima, K., & Thestrup-Pedersen, K. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.9.4545 · Cited by 180
Regulation of TGF-β Response During T Cell Activation Is Modulated by IL-10
Cottrez, F., & Groux, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.773 · Cited by 178
Negrier, S., Perol, D., Menetrier-Caux, C., Escudier, B., Pallardy, M., Ravaud, A., Douillard, J.-Y., Chevreau, C., Lasset, C., & Blay, J.-Y. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.121 · Cited by 176
Wogensen, L., Huang, X., & Sarvetnick, N. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.175 · Cited by 174
Loercher, A. E., Nash, M. A., Kavanagh, J. J., Platsoucas, C. D., & Freedman, R. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6251 · Cited by 173
Yang, A. S., & Lattime, E. C. (2003) · PubMed · Cited by 165
Santin, A. D., Hermonat, P. L., Ravaggi, A., Bellone, S., Pecorelli, S., Roman, J. J., Parham, G. P., & Cannon, M. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4729-4737.2000 · Cited by 161
Regulation of Tumor Growth and Metastasis by Interleukin-10: The Melanoma Experience
Huang, S., Ullrich, S. E., & Bar-Eli, M. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313532 · Cited by 159
Induction of CD4+ T Cell Alloantigen-Specific Hyporesponsiveness by IL-10 and TGF-β
Zeller, J. C., Panoskaltsis-Mortari, A., Murphy, W. J., Ruscetti, F. W., Narula, S., Roncarolo, M. G., & Blazar, B. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3684 · Cited by 159
Saio, M., Radoja, S., Marino, M., & Frey, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5583 · Cited by 157
Antimetastatic and Antitumor Activities of Interleukin 10 in a Murine Model of Breast Cancer
Kundu, N., Beaty, T. L., Jackson, M. J., & Fulton, A. M. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.8.536 · Cited by 154
Chau, G., Wu, C.-W., Lui, W., Chang, T.-J., Kao, H.-L., Wu, L., King, K., Loong, C., Hsia, C.-Y., & Chi, C. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00015 · Cited by 149
Förtsch, D., Röllinghoff, M., & Stenger, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.978 · Cited by 147
Lu, C. S., Soria, J., Tang, X., Xu, X.-C., Wang, L., Mao, L., Lotan, R., Kemp, B. L., Bekele, B. N., Feng, L., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.091 · Cited by 143
IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma
Howell, W., Turner, S. T., Bateman, A. C., & Theaker, J. M. (2001) · Genes and Immunity · doi:10.1038/sj.gene.6363726 · Cited by 142
Nemunaitis, J. J., Fong, T. C., Shabe, P., Martineau, D., & Ando, D. G. (2001) · Cancer Investigation · doi:10.1081/cnv-100102550 · Cited by 131
Danger signals: a time and space continuum
Škoberne, M., Beignon, A., & Bhardwaj, N. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.04.001 · Cited by 127
Interleukin-10-mediated inhibition of free radical generation in macrophages
Dokka, S., Shi, X., Leonard, S. S., Wang, L., Castranova, V., & Rojanasakul, Y. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.6.l1196 · Cited by 126
Interleukin‐10 in viral diseases and cancer: exiting the labyrinth?
Vicari, A. P., & Trinchieri, G. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00216.x · Cited by 120
HLA-G and IL-10 expression in human cancer--different stories with the same message.
Urosevic, M., & Dummer, R. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(03)00024-5 · Cited by 113
IL-10 stimulatory effects on human NK cells explored by gene profile analysis
D, S. M. M., Panelli, M. C., Wang, E., Rossi, C. R., Pilati, P., Nitti, D., Lise, M., & Marincola, F. M. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364135 · Cited by 113
Self-citationA Single Amino Acid Determines the Immunostimulatory Activity of Interleukin 10
Ding, Y., Qin, L., Kotenko, S. V., Pestka, S., & Bromberg, J. S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.213 · Cited by 111
Petersson, M., Charo, J., Salazar‐Onfray, F., Noffz, G., Mohaupt, M., Qin, Z., Klein, G., Blankenstein, T. J. F., & Kiessling, R. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2099 · Cited by 109
Chang, A. E., Li, Q., Jiang, G., Sayre, D. M., Braun, T., & Redman, B. G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.023 · Cited by 109
Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels
Bohlen, H., Kessler, M. M., Sextro, M., Diehl, V., & Tesch, H. (2000) · Annals of Hematology · doi:10.1007/s002770050564 · Cited by 104
Sredni, B., Weil, M., Khomenok, G. A., Lebenthal, I., Teitz, S., Mardor, Y., Ram, Z., Orenstein, A., Kershenovich, A., Michowiz, S. D., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3179 · Cited by 100
Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development
Šturlan, S., Oberhuber, G., Beinhauer, B. G., Tichy, B., Kappel, S., Wang, J., & Rogy, M. A. (2001) · Carcinogenesis · doi:10.1093/carcin/22.4.665 · Cited by 99
Bhattacharyya, S., Ghosh, S. T., Jhonson, P. L., Bhattacharya, S. K., & Majumdar, S. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1499-1507.2001 · Cited by 99
Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10
Cervenak, L., Morbidelli, L., Donati, D., Donnini, S., Kambayashi, T., Wilson, J. L., Axelson, H., Castaños‐Vélez, E., Ljunggren, H., Malefyt, R. D. W., et al. (2000) · Blood · doi:10.1182/blood.v96.7.2568 · Cited by 97
IL-10 Is a Central Regulator of Cyclooxygenase-2 Expression and Prostaglandin Production
Berg, D., Zhang, J., Lauricella, D. M., & Moore, S. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2674 · Cited by 95
Principles of tumor immunosurveillance and implications for immunotherapy
Ochsenbein, A. F. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700540 · Cited by 90
Kurte, M., López, M. N., Aguirre, A., Escobar, A. F., Aguillón, J. C., Charo, J., Larsen, C. G., Kiessling, R. W., & Salazar‐Onfray, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1731 · Cited by 85
Gerard, C. M., Bruyns, C., Delvaux, A., Baudson, N., Dargent, J., Goldman, M., & Velu, T. J. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.1-23 · Cited by 84
Cutting Edge: IL-10-Producing CD4+ T Cells Mediate Tumor Rejection
Segal, B. M., Glass, D. D., & Shevach, E. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.1 · Cited by 80
Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells.
Vora, M. I., Romero, L. I., & Karasek, M. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.821 · Cited by 78
Interleukin‐10‐induced CD8 cell proliferation
Rowbottom, Lepper, Garland, Cox, Corley, Oakhill, & Steward (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00828.x · Cited by 73
Adris, S., Klein, S., Jasnis, M. A., Chuluyán, E., Ledda, M. F., Bravo, A., Carbone, C., Chernajovsky, Y., & Podhajcer, O. L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301012 · Cited by 72
Characterization of a Novel CC Chemokine, HCC-4, Whose Expression Is Increased by Interleukin-10
Hedrick, J. A., Helms, A., Vicari, A. P., & Zlotnik, A. (1998) · Blood · doi:10.1182/blood.v91.11.4242 · Cited by 62
Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma
Czarneski, J., Lin, Y.-C., Chong, S. Y., McCarthy, B. A., Fernandes, H., Parker, G. A., Mansour, A., Huppi, K. E., Marti, G. E., & Raveche, E. S. (2004) · Leukemia · doi:10.1038/sj.leu.2403244 · Cited by 53
Jinquan, T., Quan, S., Jacobi, H., MADSEN, H. O., Glue, C., Skov, P. S., Malling, H., & Poulsen, L. K. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00954.x · Cited by 53
Matar, P., Rozados, V. R., Gervasoni, S. I., & Scharovsky, O. G. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00028-x · Cited by 53
Immune system versus tumor: shifting the balance in favor of DCs and effective immunity
Kaufman, H. L., & Disis, M. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21148 · Cited by 52
Kang, S. S., & Allen, P. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5382 · Cited by 50
Importance of IL-10 for CTLA-4-Mediated Inhibition of Tumor-Eradicating Immunity
Jovasevic, V. M., Gorelik, L., Bluestone, J. A., & MOKYR, M. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1449 · Cited by 46
Interleukin-10, interleukin-6 and interferon-γ gene polymorphisms in melanoma patients
Martínez‐Escribano, J., Moya‐Quiles, M. R., Muro, M., Montes‐Ares, O., Hernández‐Caselles, T., Frías, J. F., & Álvarez-López, M. R. (2002) · Melanoma Research · doi:10.1097/00008390-200209000-00008 · Cited by 44
IL-10 Induces Regulatory T Cell Apoptosis by Up-Regulation of the Membrane Form of TNF-α
Marra, L. E., Zhang, Z. X., Joe, B., Campbell, J., Levy, G. A., Penninger, J. M., & Zhang, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1028 · Cited by 42
Seo, N., Hayakawa, S., & TOKURA, Y. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00015-9 · Cited by 42
IL-10 enhances IL-2-induced proliferation and cytotoxicity by human intestinal lymphocytes
Ebert, E. C. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01147.x · Cited by 41
Guiducci, C., Carlo, E. D., Parenza, M., Hitt, M., Giovarelli, M., Musiani, P., & Colombo, M. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4026 · Cited by 38
Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines
D, S. M. M., Rossi, C. R., Nitti, D., Lise, M., & Marincola, F. M. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00032-5 · Cited by 35
Self-citationKim, B.-G., Joo, H., Chung, I.-S., Chung, H. Y., Woo, H.-J., & Yun, Y. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620000123 · Cited by 34
Fiehn, C., Paleolog, E. M., & Feldmann, M. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00286.x · Cited by 22
In vivo effects of locally secreted IL-10 on the murine antitumor immune response
Barth, R. J., Coppola, M. A., & Green, W. R. (1996) · Annals of Surgical Oncology · doi:10.1007/bf02305668 · Cited by 19
Tao, M., Li, Y., Nayini, J., Sivaraman, S., Song, S., Larson, A. W., Toofanfard, M., Chen, H., Venugopal, P., & Preisler, H. D. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109057966 · Cited by 18
Cited by
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Green, M. R., Monti, S., Rodig, S. J., Juszczynski, P., Currie, T., O'Donnell, E., Chapuy, B., Takeyama, K., Neuberg, D., Golub, T. R., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282780 · Cited by 1,305
NK cells and cancer: you can teach innate cells new tricks
Morvan, M. G., & Lanier, L. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.5 · Cited by 1,162
Metadata
- Authors
- Mocellin, S., Marincola, F. M., & Young, H. A.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-10-04
- Volume
- 78
- Issue
- 5
- Pages
- 1043-1051
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2130290528
- Cited by
- 402
- References
- 121
- FWCI
- 5.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.